Batch of Tofajak Tablets earlier classified as NSQ now flagged as Spurious Dr. Divya Colin4 May 2025 6:00 PM ISTNew Delhi: Through a recent revised drug alert, the Central Drugs Standard Control Organization (CDSCO) has classified a batch of Tofacitinib Tablets...
Certain biologics May Reduce Infection Risk among elderly with Psoriasis: JAMA Dr Riya Dave4 April 2025 8:15 PM ISTA new cohort study published in Journal of American Medical Association suggests that biologics targeting IL-12, IL-23, and IL-17 may be associated...
Synokem Pharmaceutical Gets CDSCO Panel Nod To study Tofacitinib Extended Release Tablets Dr. Divya Colin19 March 2025 6:00 PM ISTNew Delhi: Synokem Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Tofacitinib Outperforms Azathioprine in Treating Alopecia Areata, New Study Finds Medha Baranwal23 Dec 2024 8:30 PM ISTPakistan: A recent double-blind, randomized controlled trial has provided new insights into the efficacy and safety of two alopecia areata (AA)...
Statin Use Key to Reducing CV Risk in Rheumatoid Arthritis Patients on Tofacitinib: ORAL Surveillance Analysis Medha Baranwal22 Nov 2024 2:00 AM ISTUSA: A recent post hoc analysis of the ORAL Surveillance trial has highlighted the essential role of statins in mitigating major adverse...
Tofacitinib may Improve Itching and Other Symptoms Among Psoriasis Patients with PsA: Study Dr. Shravani Dali28 April 2024 9:00 PM ISTTofacitinib may Improve Itching and Other Symptoms Among Psoriasis Patients with PsA suggests a new study published in the Journal of the European...
New Study Reveals Comparable Postoperative Risks of Tofacitinib and Biologics in Ulcerative Colitis Patients Dr.Niharika Harsha B15 April 2024 6:45 AM ISTIn a significant breakthrough, a recent multicenter retrospective study has shed light on the postoperative outcomes of ulcerative colitis (UC)...
Study shows 'bidirectional' benefit of tofacitinib in rheumatoid arthritis patients with comorbid type 2 diabetes: Study Medha Baranwal27 March 2024 8:00 PM ISTItaly: Treatment with tofacitinib in rheumatoid arthritis (RA) with type 2 diabetes (T2D) may simultaneously improve inflammatory disease activity and...
Breakthrough Treatment for Polymorphic Light Eruption: Tofacitinib Shows Promise in Resistant Cases Dr.Niharika Harsha B27 Feb 2024 10:15 PM ISTA recent study has unveiled promising results for individuals suffering from polymorphous light eruption (PMLE), a sun-induced skin condition...
JAK inhibitors show promising efficacy in rheumatoid arthritis treatment Isra Zaman3 Nov 2023 9:30 AM ISTA retrospective multicenter study conducted by Japanese researchers has found that Janus kinase (JAK) inhibitors, a class of drugs used to treat...
Oral tofacitinib, novel alternative treatment for resistant alopecia areata among children Medha Baranwal27 Oct 2023 10:30 AM ISTChina: New research has demonstrated the safety and effectiveness of oral tofacitinib as a treatment option for pediatric alopecia areata (AA),...
